Skip to content
OpenCapital
Get started

Eikon Therapeutics, Inc. EIKN Total debt

Total debt at other companies

MYR Group logo
MYR GroupMYRG
$61.52M-53.5%
Cabot Corporation logo
Cabot CorporationCBT
$1.04B-18.9%
Unifirst logo
UnifirstUNF
$79.89M+12.7%
HES
Hess MidstreamHESM
$3.77B+5.6%
Main Street Capital logo
Main Street CapitalMAIN
$2.53B+12.3%
Belden logo
BeldenBDC
$1.38B+5.4%

Other financials

Income statement

See full
Operating income-$87.3M-22.3%
Net income-$83.0M-21.6%
EPS (diluted)-$2.46+90.9%

Balance sheet

See full
Cash & equivalents$161.2M-21.2%
Total equity$550.7M+186%
Total assets$850.8M—

Cash flow

See full
Operating cash flow-$89.8M-64.7%
CapEx$262.0K-98.8%
Free cash flow-$90.1M-17.1%

Valuation

See full
Market cap$514.86M—

Where this comes from

Calculated from Eikon Therapeutics, Inc. ’s reported figures.

-finance lease liabilities=$254.83M

Plus components not separately reported this period.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eikon Therapeutics, Inc. 's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eikon Therapeutics, Inc. 's total debt?
Eikon Therapeutics, Inc. (EIKN) reported total debt of $254.83M in Q1 2026.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.